ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed Media Release for the Quarter and Half Year ended September 30, 202327-10-2023
ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed Media Release for the Quarter and Half Year ended September 30, 2023ASTEC LIFESCIENCES LIMITED - 533138 - Outcome Of Board Meeting Held On October 27, 2023
Please find enclosed outcome of Board Meeting held on October 27, 2023ASTEC LIFESCIENCES LIMITED - 533138 - Board Meeting Outcome for Outcome Of Board Meeting Held On October 27, 2023
Kindly find enclosed Outcome of Board Meeting held on October 27, 2023ASTEC LIFESCIENCES LIMITED - 533138 - Board Meeting Intimation for Intimation Of Board Meeting As Per Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2023 ,inter alia, to consider and approve Notice is hereby given pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, that the Meeting of the Board of Directors of Astec LifeSciences Limited ('the Company') is scheduled to be held on Friday, 27th October, 2023, to, inter alia, consider and approve the Standalone and Consolidated Unaudited Financial Results for the Quarter and Half Year ended 30th September, 2023, after these results are reviewed by the Audit Committee and the Board of Directors may also consider and approve enhancement in the existing limit of issuance of Debenture(s) or Debt Securities upto such limit as may be deemed appropriate by the Board, subject to such other approval(s) as may be applicable.ASTEC LIFESCIENCES LIMITED - 533138 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Kindly find enclosed the compliance certificate received from Registrar and Share Transfer Agent (RTA) of Astec LifeSciences Limited for the Quarter ended September 30, 2023.ASTEC LIFESCIENCES LIMITED - 533138 - Closure of Trading Window
Kindly find enclosed the intimation of the Trading Window Closure for the Quarter and Half Year ended September 30, 2023.ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Intimation under Regulation 30 of the Securities and Exchange Board of India (LODR) Regulations, 2015 pertaining to ESOP 2012ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Allotment
Allotment of 4,900 (Four Thousand and Nine Hundred) Rated, Listed, Unsecured, Redeemable, Taxable, Non-Convertible Debentures of Nominal value of Rs.1,00,000/-(Rupees One Lakh Only) each, aggregating to Rs.49,00,00,000/-(Rupees Forty Nine Crore Only) on private placement basis by Astec LifeSciences Limited.ASTEC LIFESCIENCES LIMITED - 533138 - Intimation / Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Pendency Of Litigation(S) Or Dispute(S)
Please find enclosed the disclosure under Regulation 30 of the SEBI Listing Regulations regarding pendency of litigation(s) or dispute(s).ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
This is to inform you that the Nomination and Remuneration Committee of Board of Directors of the Company has approved the allotment of 2,000 Equity Shares of Face Value of Rs.10 each, upon exercise of Options granted under Employee Stock Option Scheme 2015 ("ESOS 2015") at an exercise price of Rs.387.35 per Option.